• Blog - Diseases & Conditions

    NSAIDs and Antiplatelet Agents: Bleeding Risks

    Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) and antiplatelet agents are both cornerstone therapies in modern medicine, widely used for pain, inflammation, and cardiovascular disease prevention. NSAIDs, such as ibuprofen and naproxen, are frequently used for musculoskeletal pain and arthritis, while antiplatelet drugs like aspirin and clopidogrel are vital for preventing heart attacks, strokes, and other thrombotic events. However, the combination of NSAIDs and antiplatelet agents raises a significant clinical concern: an increased risk of bleeding, particularly in the gastrointestinal (GI) tract. This synergistic effect is well-documented and can lead to serious, sometimes life-threatening complications. Understanding the pharmacodynamic interaction, reviewing clinical evidence,…

  • Blog - Diseases & Conditions

    NSAIDs and Anticoagulants: Bleeding Risks

    Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) and anticoagulants are two classes of medications widely used across various medical disciplines. NSAIDs, such as ibuprofen and naproxen, are commonly employed to relieve pain, inflammation, and fever. On the other hand, anticoagulants, including warfarin, rivaroxaban, and apixaban, are prescribed to prevent or treat thromboembolic events such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke in atrial fibrillation. While each medication serves a vital therapeutic role, their concurrent use can significantly elevate the risk of bleeding. This concern becomes particularly relevant in populations such as the elderly, individuals with chronic pain conditions, and…